139 related articles for article (PubMed ID: 38536840)
1. Association of spironolactone use with risk of urinary tract cancer in the general population: A matched population-based cohort study.
Chen LC; Yang HJ; Yu BH; Lee MS; Lin HY; Chiou WY; Liu DW; Hsu FC; Chew CH; Hung SK
PLoS One; 2024; 19(3):e0300391. PubMed ID: 38536840
[TBL] [Abstract][Full Text] [Related]
2. Risk of Malignant Neoplasms of Kidney and Bladder in a Cohort Study of the Diabetic Population in Taiwan With Age, Sex, and Geographic Area Stratifications.
Chen HF; Chen SW; Chang YH; Li CY
Medicine (Baltimore); 2015 Sep; 94(38):e1494. PubMed ID: 26402804
[TBL] [Abstract][Full Text] [Related]
3. Risk of Cancer after Lower Urinary Tract Infection: A Population-Based Cohort Study.
Huang CH; Chou YH; Yeh HW; Huang JY; Yang SF; Yeh CB
Int J Environ Res Public Health; 2019 Jan; 16(3):. PubMed ID: 30704106
[TBL] [Abstract][Full Text] [Related]
4. Higher risk of urothelial carcinoma in the upper urinary tract than in the urinary bladder in hemodialysis patients.
Hsiao PJ; Hsieh PF; Chang CH; Wu HC; Yang CR; Huang CP
Ren Fail; 2016 Jun; 38(5):663-70. PubMed ID: 26956094
[TBL] [Abstract][Full Text] [Related]
5. Associations between interventions for urolithiasis and urinary tract cancer among patients in Taiwan: The effect of early intervention.
Lin CL; Huang WT; Fan WC; Feng YH; Lin CH; Lin CS; Lu CC; Cheng TC; Tsao CJ; Lin SH
Medicine (Baltimore); 2016 Dec; 95(49):e5594. PubMed ID: 27930581
[TBL] [Abstract][Full Text] [Related]
6. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.
Lai MN; Wang SM; Chen PC; Chen YY; Wang JD
J Natl Cancer Inst; 2010 Feb; 102(3):179-86. PubMed ID: 20026811
[TBL] [Abstract][Full Text] [Related]
7. Spironolactone use and risk of incident cancers: a retrospective, matched cohort study.
Mackenzie IS; Morant SV; Wei L; Thompson AM; MacDonald TM
Br J Clin Pharmacol; 2017 Mar; 83(3):653-663. PubMed ID: 27735065
[TBL] [Abstract][Full Text] [Related]
8. Gout patients have an increased risk of developing most cancers, especially urological cancers.
Chen CJ; Yen JH; Chang SJ
Scand J Rheumatol; 2014; 43(5):385-90. PubMed ID: 24825466
[TBL] [Abstract][Full Text] [Related]
9. Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from northeastern Taiwan.
Chen CL; Chiou HY; Hsu LI; Hsueh YM; Wu MM; Wang YH; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):101-10. PubMed ID: 20056628
[TBL] [Abstract][Full Text] [Related]
10. Urinary tract stone raises subsequent risk for urinary tract cancer: a population-based cohort study.
Sun LM; Lin CL; Chang YJ; Liang JA; Liu SH; Sung FC; Kao CH
BJU Int; 2013 Dec; 112(8):1150-5. PubMed ID: 24053541
[TBL] [Abstract][Full Text] [Related]
11. Urinary tuberculosis is associated with the development of urothelial carcinoma but not renal cell carcinoma: a nationwide cohort study in Taiwan.
Lien YC; Wang JY; Lee MC; Shu CC; Chen HY; Hsieh CH; Lee CH; Lee LN; Chao KM
Br J Cancer; 2013 Nov; 109(11):2933-40. PubMed ID: 24129236
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study.
Mackenzie IS; Macdonald TM; Thompson A; Morant S; Wei L
BMJ; 2012 Jul; 345():e4447. PubMed ID: 22797844
[TBL] [Abstract][Full Text] [Related]
13. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
[TBL] [Abstract][Full Text] [Related]
14. Spironolactone and the risk of urinary tract cancer in patients with hypertension: a nationwide population-based retrospective case-control study.
Chuang YW; Yu MC; Huang ST; Yang CK; Chen CH; Lo YC; Lin CL; Shu KH; Yu TM; Kao CH
J Hypertens; 2017 Jan; 35(1):170-177. PubMed ID: 27906842
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Bladder Cancer in Type 2 Diabetes Mellitus Patients: A Population-Based Cohort Study.
Pan Y; Lee CY; Lee LM; Wen YC; Huang JY; Yang SF; Hsiao CH
Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32878139
[No Abstract] [Full Text] [Related]
16. Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study.
Jiang R; Wang X; Li Z; Cai H; Sun Z; Wu S; Chen S; Hu H
BMC Urol; 2023 Sep; 23(1):150. PubMed ID: 37736725
[TBL] [Abstract][Full Text] [Related]
17. Risk of urinary tract cancers following kidney or ureter stones.
Chow WH; Lindblad P; Gridley G; Nyrén O; McLaughlin JK; Linet MS; Pennello GA; Adami HO; Fraumeni JF
J Natl Cancer Inst; 1997 Oct; 89(19):1453-7. PubMed ID: 9326915
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease and risk of kidney or urothelial malignancy: systematic review and meta-analysis.
Brooks ER; Siriruchatanon M; Prabhu V; Charytan DM; Huang WC; Chen Y; Kang SK
Nephrol Dial Transplant; 2024 May; 39(6):1023-1033. PubMed ID: 38037426
[TBL] [Abstract][Full Text] [Related]
19. Trends and sex-specific incidence of upper urinary tract cancer in Taiwan: A birth cohort study.
Chang YH; Hsu WL; Lee YK; Chiang CJ; Yang YW; You SL; Chen YC; Lai TS
Cancer Med; 2023 Jul; 12(14):15350-15357. PubMed ID: 37392179
[TBL] [Abstract][Full Text] [Related]
20. Positive association between hypertension and urinary bladder cancer: epidemiologic evidence involving 79,236 propensity score-matched individuals.
Kok VC; Zhang HW; Lin CT; Huang SC; Wu MF
Ups J Med Sci; 2018 Jun; 123(2):109-115. PubMed ID: 29911922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]